These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19962575)

  • 21. Human albumin solutions: an audit of use in three major metropolitan hospitals. Subcommittee of the Victorian Drug Usage Advisory Committee.
    Med J Aust; 1991 May; 154(10):657-60. PubMed ID: 2034144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma substitutes.
    Boldt J; Suttner S
    Minerva Anestesiol; 2005 Dec; 71(12):741-58. PubMed ID: 16288182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic Solutions of Human Albumin - The Possible Effect of Process-Induced Molecular Alterations on Clinical Efficacy and Safety.
    Farrugia A; Mori F
    J Pharm Sci; 2022 May; 111(5):1292-1308. PubMed ID: 35276228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Albumin as a drug: its biological effects beyond volume expansion.
    Bihari S; Bannard-Smith J; Bellomo R
    Crit Care Resusc; 2020 Sep; 22(3):257-265. PubMed ID: 32900333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroanesthesia and intensive care. Best evidence in anesthetic practice. Harm: albumin neither increases nor decreases mortality in critically ill patients.
    Bryson GL
    Can J Anaesth; 2002; 49(6):620; discussion 621. PubMed ID: 12067877
    [No Abstract]   [Full Text] [Related]  

  • 26. Albumin and hypovolaemia.
    Waller C
    Lancet; 2002 Jun; 359(9325):2278. PubMed ID: 12103318
    [No Abstract]   [Full Text] [Related]  

  • 27. Therapeutic plasma exchange in a single center: Ibni Sina experience.
    Arslan O; Arat M; Tek I; Ayyildiz E; Ilhan O
    Transfus Apher Sci; 2004 Jun; 30(3):181-4. PubMed ID: 15172620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of different albumin concentrations in extracorporeal circuit prime on perioperative fluid status in young children.
    Yu K; Liu Y; Hei F; Li J; Long C
    ASAIO J; 2008; 54(5):463-6. PubMed ID: 18812733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selected Proceedings of the NICHD/FDA newborn drug development initiative: Part II.
    Giacoia GP; Mattison DR
    Clin Ther; 2006 Sep; 28(9):1337-41. PubMed ID: 17062307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of manufacturing improvements on clinical safety of albumin: Australian pharmacovigilance data for 1988-2005.
    Che Y; Wilson FJ; Bertolini J; Schiff P; Maher DW
    Crit Care Resusc; 2006 Dec; 8(4):334-8. PubMed ID: 17227271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Albumin and Survival in Extremity Metastatic Bone Disease: An Analysis of Two Independent Datasets.
    Thio QCBS; Karhade AV; Pham A; Ogink PT; Ferrone ML; Schwab JH
    Nutr Cancer; 2022; 74(6):1986-1993. PubMed ID: 34581215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overview of Albumin Physiology and its Role in Pediatric Diseases.
    Chen CB; Hammo B; Barry J; Radhakrishnan K
    Curr Gastroenterol Rep; 2021 Jul; 23(8):11. PubMed ID: 34213692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complementary medicine. Searching for the evidence.
    Bensoussan A
    Aust Fam Physician; 2000 Dec; 29(12):1129-33. PubMed ID: 11140216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Albumin--biological functions and clinical significance].
    Miller A; Jedrzejczak WW
    Postepy Hig Med Dosw; 2001; 55(1):17-36. PubMed ID: 11355530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Albumin and hypovolaemia: is the Cochrane evidence to be trusted?
    Horsey P
    Lancet; 2002 Jan; 359(9300):70-2; discussion 72-3. PubMed ID: 11809206
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of albumin in the intensive care unit.
    Dubois MJ; Vincent JL
    Curr Opin Crit Care; 2002 Aug; 8(4):299-301. PubMed ID: 12386489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The New Delivery Strategy of Albumin Carrier Utilizing the Interaction with Albumin Receptors.
    Ishima Y; Maruyama T; Otagiri M; Chuang VTG; Ishida T
    Chem Pharm Bull (Tokyo); 2022; 70(5):330-333. PubMed ID: 35491188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.